{"version":"1.0","type":"link","title":"Novel Combination of Metronomic Cyclophosphamide and Darolutamide Induces Sustained Clinical Response in Heavily Treated Prostate Cancer with Prostate-Specific Membrane Antigen-Negative Liver Metastases and Rapid Disease Progression.","author_name":"Patel VM 외","author_url":"https://prs-insight.online/author/Patel%20VM","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/133228","thumbnail_width":1200,"thumbnail_height":630}